Western equine encephalitis: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Changing Category:DiseaseState to Category:Disease) |
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
||
Line 16: | Line 16: | ||
{{CMG}} | {{CMG}} | ||
'''Synonyms and Related Keywords:''' Mosquito-borne | '''Synonyms and Related Keywords:''' Mosquito-borne | ||
Line 56: | Line 56: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 17:28, 20 August 2012
Western equine encephalitis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and Related Keywords: Mosquito-borne
Epidemiology and Demographics
639 confirmed cases in the U.S. since 1964.
Risk Factors
- Epidemic disease that is difficult to predict
- Residents of endemic areas and visitors
- Persons with outdoor work and recreational activities
- Risk exposure increases as population expands into endemic areas
- Unknown overwintering cycle
Pathophysiology & Etiology
Western equine encephalitis virus, member of the family Togaviridae, genus Alphavirus. Closely related to eastern and Venezuelan equine encephalitis viruses.
History and Symptoms
Symptoms range from mild flu-like illness to frank encephalitis, coma and death.
Other Diagnostic Studies
Risk Stratification and Prognosis
Treatment
- No licensed vaccine for human use
- No effective therapeutic drug
Primary Prevention
- Control measures expensive
- Limited financial support of surveillance and prevention
Cost-Effectiveness of Therapy
- Total case costs range from $21,000 for transiently infected individuals to $3 million for severely infected individuals
- Insecticide applications can cost as much as $1.4 million depending on the size of area treated
Suggested Reading and Key General References